US Taxpayers Set to Pay $712 per Patient for Merck’s New COVID Pill

A new COVID-19 pill that can purportedly cut the risk of both hospitalization as well as death from COVID-19—by as much as 50 percent—is now in the process of getting emergency use authorization.

However, according to several researchers, the technology that this pill uses runs the risk of potentially causing cancer, although, according to one researcher we spoke with, we likely won’t know until many years later.

Regardless though, according to a contract that Merck signed with the U.S. government in 2020, once they gain authorization, Merck is set to rake in massive profits because the markup on these pills is astronomical.

Lastly, I had the opportunity to sit down and speak with Zach Voorhies, who was a senior software engineer at Google before he became a whistleblower, and he explained to me how a system that Google built, called machine learning fairness, works behind the scenes to censor what Americans, like you and me, can see, hear, and talk about.